📰 Imaging Phenomics News
Imaging Phenomics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Imaging Phenomics. Real-time updates on events, politics, business and more.
January 6, 2022
Median Technologies announces outstanding lung nodule detection (CADe[1]) performance for iBiopsy® Lung Cancer Screening  ·         iBiopsy® Lung Cancer Screening (LCS) detection performance reaches 94.9% sensitivity for a false positive rate of 1 per CT sc...
January 5, 2022
iBiopsy Lung Cancer Screening (LCS) detection performance reaches 94.9% sensitivity for a false positive rate of 1 per CT scan, a performance superior to that of lung CADe systems currently on the
January 4, 2022
Regulatory News: Median Technologies (Paris:ALMDT) (ALMDT:PA), announces the publication date for its 2021 results: Publication Date 2021 results April 26, 2022*
January 4, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
November 23, 2021
iBiopsy's Lung Cancer Screening performance (LCS) for stage 1 lung cancer reaches 93.1% sensitivity at 96.2% specificity. These results are critical for lung cancer characterization at an
October 21, 2021
Business continues to grow at a sustained pace in the first half of 2021 Two highly impactful announcements for iBiopsy and iCRO business units during Q3, 2021 Third quarter revenue
October 21, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
October 13, 2021
Regulatory News: Median Technologies (ALMDT:PA) announced today that Fredrik Brag, CEO and founder of Median Technologies, will provide a company update on October 25th, 2021 at 6:00 pm CEST during
October 6, 2021
Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares
May 7, 2021
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30th, 2021 Regulatory News: (excluding treasury shares**) (including treasury shares**) (**) pursuant to article 223-11 of the AMFs General Regulations About Median Technologies: Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We leverage the power of Imaging Phenomics to provide insights into novel therapies and treatment s...